00:00It's really an honor to be here today for this historic step forward, to expand access to a class of medications that can fundamentally change the arc of chronic disease in our country.
00:12Of course, these are the incretin or GLP-1 agonists that we've been speaking about.
00:17For nearly 150 years, my company, Eli Lilly, has been investing in America.
00:23We've been advancing science and creating high-value jobs.
Sé la primera persona en añadir un comentario